CDKN2A and glioblastoma: In the p53 pathway, while TP53 and CDKN2A/B alterations overlapped in a subset of glioblastomas and IDH1/2-mutant astrocytomas, TP53 mutation predominated in IDH1/2-mutant astrocytomas, while CDKN2A/B alterations predominated in glioblastomas.